Notification



Notification Issue Date:



Policy Attachment


Attachment to Policy # 08.01.10d


Attachment:A

Policy #:08.01.10d

Description:ICD-10 CODES AND NARRATIVES

Title:Octreotide acetate (Sandostatin® LAR Depot)


Inclusion of a code in this table does not imply reimbursement. Eligibility, benefits, limitations, exclusions, precertification/referral requirements, provider contracts, and Company policies apply.

The codes listed below are updated on a regular basis, in accordance with nationally accepted coding guidelines. Therefore, this policy applies to any and all future applicable coding changes, revisions, or updates.

In order to ensure optimal reimbursement, all health care services, devices, and pharmaceuticals should be reported using the billing codes and modifiers that most accurately represent the services rendered, unless otherwise directed by the Company.



ICD-10 CODES AND NARRATIVES

Professional and outpatient claims with a date of service on or before September 30, 2015, must be billed using ICD-9 codes. Professional and outpatient claims with a date of service on or after October 1, must be billed using ICD-10 codes.

C25.4 Malignant neoplasm of endocrine pancreas

C37 Malignant neoplasm of thymus

C70.0 Malignant neoplasm of cerebral meninges

C70.1 Malignant neoplasm of spinal meninges

C70.9 Malignant neoplasm of meninges, unspecified

C7A.00 Malignant carcinoid tumor of unspecified site

C7A.010 Malignant carcinoid tumor of the duodenum

C7A.011 Malignant carcinoid tumor of the jejunum

C7A.012 Malignant carcinoid tumor of the ileum

C7A.019 Malignant carcinoid tumor of the small intestine, unspecified portion

C7A.020 Malignant carcinoid tumor of the appendix

C7A.021 Malignant carcinoid tumor of the cecum

C7A.022 Malignant carcinoid tumor of the ascending colon

C7A.023 Malignant carcinoid tumor of the transverse colon

C7A.024 Malignant carcinoid tumor of the descending colon

C7A.025 Malignant carcinoid tumor of the sigmoid colon

C7A.026 Malignant carcinoid tumor of the rectum

C7A.029 Malignant carcinoid tumor of the large intestine, unspecified portion

C7A.090 Malignant carcinoid tumor of the bronchus and lung

C7A.091 Malignant carcinoid tumor of the thymus

C7A.092 Malignant carcinoid tumor of the stomach

C7A.093 Malignant carcinoid tumor of the kidney

C7A.094 Malignant carcinoid tumor of the foregut, unspecified

C7A.095 Malignant carcinoid tumor of the midgut, unspecified

C7A.096 Malignant carcinoid tumor of the hindgut, unspecified

C7A.098 Malignant carcinoid tumors of other sites

C7A.1 Malignant poorly differentiated neuroendocrine tumors

C7A.8 Other malignant neuroendocrine tumors

C7B.00 Secondary carcinoid tumors, unspecified site

C7B.01 Secondary carcinoid tumors of distant lymph nodes

C7B.02 Secondary carcinoid tumors of liver

C7B.03 Secondary carcinoid tumors of bone

C7B.04 Secondary carcinoid tumors of peritoneum

C7B.09 Secondary carcinoid tumors of other sites

C7B.8 Other secondary neuroendocrine tumors

D13.7 Benign neoplasm of endocrine pancreas

D15.0 Benign neoplasm of thymus

D32.0 Benign neoplasm of cerebral meninges

D32.1 Benign neoplasm of spinal meninges

D32.9 Benign neoplasm of meninges, unspecified

D3A.00 Benign carcinoid tumor of unspecified site

D3A.010 Benign carcinoid tumor of the duodenum

D3A.011 Benign carcinoid tumor of the jejunum

D3A.012 Benign carcinoid tumor of the ileum

D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion

D3A.020 Benign carcinoid tumor of the appendix

D3A.021 Benign carcinoid tumor of the cecum

D3A.022 Benign carcinoid tumor of the ascending colon

D3A.023 Benign carcinoid tumor of the transverse colon

D3A.024 Benign carcinoid tumor of the descending colon

D3A.025 Benign carcinoid tumor of the sigmoid colon

D3A.026 Benign carcinoid tumor of the rectum

D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion

D3A.090 Benign carcinoid tumor of the bronchus and lung

D3A.091 Benign carcinoid tumor of the thymus

D3A.092 Benign carcinoid tumor of the stomach

D3A.094 Benign carcinoid tumor of the foregut, unspecified

D3A.095 Benign carcinoid tumor of the midgut, unspecified

D3A.096 Benign carcinoid tumor of the hindgut, unspecified

D3A.098 Benign carcinoid tumors of other sites

D3A.8 Other benign neuroendocrine tumors

D42.0 Neoplasm of uncertain behavior of cerebral meninges

D42.1 Neoplasm of uncertain behavior of spinal meninges

D42.9 Neoplasm of uncertain behavior of meninges, unspecified

E16.1 Other hypoglycemia

E16.3 Increased secretion of glucagon

E16.4 Increased secretion of gastrin

E16.8 Other specified disorders of pancreatic internal secretion

E22.0 Acromegaly and pituitary gigantism

E24.8 Other Cushing's syndrome

E34.0 Carcinoid syndrome

Version Effective Date: 09/20/2017
Version Issued Date: 09/20/2017
Version Reissued Date: N/A

Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.